ArticlePloS one2012

Erythroid promoter confines FGF2 expression to the marrow after hematopoietic stem cell gene therapy and leads to enhanced endosteal bone formation.

Xianmei Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.